RVMD
NASDAQ · Biotechnology
Revolution Medicines Inc
$193.06
-7.09 (-3.54%)
Performance
1D
—
1W
-3.32%
1M
-0.46%
3M
-4.43%
6M
+32.54%
1Y
+201.28%
YTD
+144.32%
Open$197.31
Previous Close$200.15
Day High$198.95
Day Low$189.76
52W High$224.31
52W Low$58.00
Volume—
Avg Volume2.10M
Market Cap41.37B
P/E Ratio—
EPS$-4.80
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$196.73
Below
SMA 200
$158.23
Above
RSI (14)
52.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
31 analysts
Price Target
-40.9% upside
Current
$193.06
$193.06
Target
$114.11
$114.11
$80.83
$114.11 avg
$120.13
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.27B | 6.60B | 6.07B |
| Net Income | 320.45M | 295.32M | 319.17M |
| Profit Margin | 4.4% | 4.5% | 5.3% |
| EBITDA | 413.26M | 366.06M | 402.03M |
| Free Cash Flow | 328.07M | 289.36M | 393.55M |
| Rev Growth | +0.4% | +7.5% | +13.8% |
| Debt/Equity | 0.86 | 0.80 | 0.86 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.61 | -0.78% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $462.08 | -0.68% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $169.41 | -0.85% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $540.53 | -1.34% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $929.22 | +1.44% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $151.64 | -3.17% | 7.7 | 20.98B |